Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6187830 | Journal of Reproductive Immunology | 2016 | 6 Pages |
Abstract
In the field of in vitro fertilization (IVF), useful markers for the prediction of successful implantation for oocyte or embryo selection are essential. It has been reported that sHLA-G (sHLA-G1/HLA-G5) could be detected in the supernatant of the fertilized embryo and in follicular fluid samples (FFs), and that the presence of sHLA-G was related to successful implantation. If sHLA-G could be used as a marker of oocyte selection from multiple FFs, oocytes could be selected without physical contact, thus reducing the likelihood of damage. To investigate the potential for sHLA-G as a marker of oocyte selection from multiple FFs in one patient, protein levels of total protein, sHLA-G, and sHLA-I (sHLA-A, B, and C) were examined in FFs. The variation among multiple FFs in total protein level and sHLA-G level was not related to successful pregnancy. The average sHLA-I levels did not differ in the successful implantation and unsuccessful implantation groups, indicating that sHLA-I levels were not related to successful pregnancy. Furthermore, sHLA-G in FFs was not detected by western blotting, despite being detected by ELISA, while sHLA-I was detected by both ELISA and western blot. These data suggest that sHLA-G in FF might not be a useful marker for oocyte selection as measurements of sHLA-G were inconsistent and there was no association with successful pregnancy. Further, more rigorously tested ELISA systems for detecting sHLA-G in body fluids are necessary before the utility of sHLA-G for diagnosis can be established.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Noriko Ouji-Sageshima, Katsuya Yuui, Mari Nakanishi, Nobuyoshi Takeda, Yasushi Odawara, Masanori Yamashita, Hiroshi Iwayama, Keiko Awai, Hirotsugu Hashimoto, Daniel E. Geraghty, Akiko Ishitani, Katsuhiko Hatake, Toshihiro Ito,